Skip to content
2000
Volume 25, Issue 6
  • ISSN: 1871-5265
  • E-ISSN: 2212-3989

Abstract

Background

Streptococcal Toxic Shock Syndrome (STSS) is a life-threatening condition caused by bacterial toxins. The STSS triad encompasses high fever, hypotensive shock, and a “sunburn-like” rash with desquamation. STSS, like Toxic Shock Syndrome (TSS), is a rare complication of streptococcal infections caused by Group A (GAS), (). is the most frequently isolated bacterial species associated with TSS. Risk factors for STSS include older age, skin wounds, recent viral infection with open sores, recent surgery, nasal packing, use of tampons or other devices, such as menstrual cups/contraceptive sponges/diaphragms, or any other chronic illness, like diabetes or alcohol/drug abuse. Our case presents a patient who did not have any of these risk factors.

Case Presentation

A 25-year-old male was admitted to the Intensive Care Unit (ICU) after requiring intubation with mechanical ventilation and pressor support in the setting of septic shock. Septic arthritis was suspected, and blood and bone cultures were positive for . Arthrocentesis of the affected knee (with fluid analysis and cytology) was positive for . Infectious disease was consulted and the patient was empirically started on antibiotics. Kidney function continued to worsen, requiring hemodialysis. He no longer demonstrated brainstem reflexes, which prompted neurology consultation to rule out central nervous system dissemination.

Superantigens are pyrogenic exotoxins secreted by different strains of and are responsible for the many symptoms of STSS that patients present with. Throat infections by the bacteria, leading to streptococcal pharyngitis, are mediated by toxin release and known to cause scarlet fever and, very rarely, STSS. The post-infectious non-pyogenic, non-suppurative syndromes of GAS are autoimmune in nature, which include rheumatic fever, acute glomerulonephritis, and very rarely, reactive arthritis. This cross-reactivity of antibodies with body tissue a mechanism of molecular mimicry can follow streptococcal infections, like streptococcal pharyngitis. Renal disease can also occur after a localized skin infection, also known as streptococcal impetigo.

Despite the relationship of STSS with throat infections, there seem to be no reported cases of STSS secondary to septic arthritis in adult patients with no pertinent past medical history or other risk factors that could contribute to the condition.

Conclusion

Streptococcal septic arthritis is an uncommon orthopedic emergency with high morbidity and mortality that requires emergent medical management. Septic arthritis needs to be treated with systemic antibiotics and joint aspiration, also known as arthrocentesis, which may be required more than once for complete recovery and avoidance of joint destruction. STSS is a very rare complication of streptococcal septic arthritis and monitoring of organ failure and hemodynamic instability is paramount for patient’s management and survival.

Loading

Article metrics loading...

/content/journals/iddt/10.2174/0118715265326740241218080319
2025-01-29
2025-10-18
Loading full text...

Full text loading...

References

  1. BrouwerS. Rivera-HernandezT. CurrenB.F. Pathogenesis, epidemiology and control of group A Streptococcus infection.Nat. Rev. Microbiol.202321743144710.1038/s41579‑023‑00865‑7 36894668
    [Google Scholar]
  2. RahimkhaniM. MordadiA.R. Survey of the lethal effect of ciprofloxacin and supernatant isolated from Staphylococcus aureus under the stress of ciprofloxacin on methicillin-resistant Staphylococcus aureus strains isolated from clinical specimens.J Payavard Salamat2022156578584
    [Google Scholar]
  3. RahimkhaniM. RajabiZ. MRSA and VRSA isolated from patients hospitalized in the ICU, NICU and surgical departments of hospitals.Proc. Natl. Acad. Sci., India, Sect. B Biol. Sci.202494365365710.1007/s40011‑024‑01558‑8
    [Google Scholar]
  4. BrouwerS. BarnettT.C. Rivera-HernandezT. RohdeM. WalkerM.J. Streptococcus pyogenes adhesion and colonization.FEBS Lett.2016590213739375710.1002/1873‑3468.12254 27312939
    [Google Scholar]
  5. FiedlerT. Streptococcus pyogenes biofilms-formation, biology, and clinical relevance.Front. Cell. Infect. Microbiol.2015510.3389/fcimb.2015.00015 25717441
    [Google Scholar]
  6. WangB. ClearyP.P. Intracellular invasion by Streptococcus pyogenes: Invasins, host receptors, and relevance to human disease.Microbiol. Spectr.20197410.1128/microbiolspec.GPP3‑0049‑2018 31267891
    [Google Scholar]
  7. HenninghamA. BarnettT.C. MaamaryP.G. WalkerM.J. Pathogenesis of group A streptococcal infections.Discov. Med.20121372329342 22642914
    [Google Scholar]
  8. FerrettiJ. StevensD. FischettiV. Streptococcus pyogenes: Basic Biology to Clinical Manifestations.Oklahoma City, OKUniversity of Oklahoma Health Sciences Center2016 26866208
    [Google Scholar]
  9. NelsonG.E. PondoT. ToewsK.A. Epidemiology of invasive group A Streptococcal infections in the United States, 2005-2012.Clin. Infect. Dis.201663447848610.1093/cid/ciw248 27105747
    [Google Scholar]
  10. WalkerM.J. BarnettT.C. McArthurJ.D. Disease manifestations and pathogenic mechanisms of Group A Streptococcus.Clin. Microbiol. Rev.201427226430110.1128/CMR.00101‑13 24696436
    [Google Scholar]
  11. SchmitzM. RouxX. HuttnerB. PuginJ. Streptococcal toxic shock syndrome in the intensive care unit.Ann. Intensive Care2018818810.1186/s13613‑018‑0438‑y 30225523
    [Google Scholar]
  12. StevensD.L. Invasive group A Streptococcus infections.Clin. Infect. Dis.199214121310.1093/clinids/14.1.2 1571429
    [Google Scholar]
  13. Norrby-TeglundA. KotbM. Host-microbe interactions in the pathogenesis of invasive group A streptococcal infections.J. Clin. Invest.20001071131910.1172/JCI11884
    [Google Scholar]
  14. StevensD.L. BryantA.E. Severe Group A Streptococcal Infections.Oklahoma City, OKUniversity of Oklahoma Health Sciences Center2016 26866227
    [Google Scholar]
  15. GotoM. GotohM. MitsuiY. Pyogenic knee arthritis caused by group A β-hemolytic Streptococcus: A toxic shock-prevented case.Kurume Med. J.2014611-2313410.2739/kurumemedj.MS63002 25152247
    [Google Scholar]
  16. KerrD.L. LoraasE.K. LinksA.C. BroganT.V. SchmaleG.A. Toxic shock in children with bone and joint infections: A review of seven years of patients admitted to one intensive care unit.J. Child. Orthop.201711538739210.1302/1863‑2548.11.170058 29081854
    [Google Scholar]
  17. Le HelloS. DoloyA. BaumannF. Clinical and microbial characteristics of invasive Streptococcus pyogenes disease in New Caledonia, a region in Oceania with a high incidence of acute rheumatic fever.J. Clin. Microbiol.201048252653010.1128/JCM.01205‑09 19955276
    [Google Scholar]
  18. SakuraiA. OkahashiN. NakagawaI. Streptococcus pyogenes infection induces septic arthritis with increased production of the receptor activator of the NF-kappaB ligand.Infect. Immun.200371106019602610.1128/IAI.71.10.6019‑6026.2003 14500523
    [Google Scholar]
  19. MillerJ.M. BinnickerM.J. CampbellS. A guide to utilization of the microbiology laboratory for diagnosis of infectious diseases: 2018 update by the infectious diseases society of America and the American society for microbiologya.Clin. Infect. Dis.2018676e1e9410.1093/cid/ciy381 29955859
    [Google Scholar]
  20. AlwattarB.J. StrongwaterA. SalaD.A. Streptococcal toxic shock syndrome presenting as septic knee arthritis in a 5-year-old child.J. Pediatr. Orthop.200828112412710.1097/bpo.0b013e31815b4dfd 18157057
    [Google Scholar]
  21. IbiaE.O. ImoisiliM. PikisA. Group A β-hemolytic streptococcal osteomyelitis in children.Pediatrics20031121e22e2610.1542/peds.112.1.e22 12837901
    [Google Scholar]
  22. ChadhaA. JamalW. AzizA.R.A. RotimiV.O. Overwhelming Streptococcus pyogenes sepsis in an elderly patient with septic arthritis.J. Infect. Public Health201811343443510.1016/j.jiph.2017.08.011 28882472
    [Google Scholar]
  23. HansenN.S. LethS. NielsenL.T. Toxic shock syndrome.Ugeskr. Laeger202018220V11190673 32400378
    [Google Scholar]
  24. PeetermansM. de ProstN. EckmannC. Norrby-TeglundA. SkredeS. De WaeleJ.J. Necrotizing skin and soft-tissue infections in the intensive care unit.Clin. Microbiol. Infect.202026181710.1016/j.cmi.2019.06.031 31284035
    [Google Scholar]
/content/journals/iddt/10.2174/0118715265326740241218080319
Loading
/content/journals/iddt/10.2174/0118715265326740241218080319
Loading

Data & Media loading...

This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error
Please enter a valid_number test